IRADIMED’s updated analyst narrative keeps the fair value anchor steady at $118.67, so the headline price target reference point in the model is unchanged. That level is now being echoed by bullish ...
Claritev, a healthcare technology, data, and insights company, today announced that Fernando Schwartz, Ph.D., Senior Vice President and Chief AI Officer, has been named to the DataIQ 100 North America ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results